Drug Discovery Nexus Conference 2025
22nd BioPharma Drug Discovery Nexus Conference 2025
Brussels, Belgium
29th-30th April 2025
Join us at the Drug Discovery Nexus Conference 2025, an essential gathering for scientists and chemists dedicated to advancing pharmaceutical research and development. This prestigious event will be held on April 29-30, 2025, in the picturesque city of Brussels, Belgium, offering a unique platform to explore groundbreaking innovations in drug discovery.
Dr. Ewa Gajewska, Head of Product Management for SYNTHIATM Retrosynthesis Software at Merck KGaA, will deliver a keynote address that promises to be a highlight of the conference. Dr. Gajewska will present the transformative capabilities of SYNTHIA, a cutting-edge tool that is revolutionizing synthetic planning with its AI-driven approach. Her insights will be invaluable for professionals seeking to enhance their workflows and generate new intellectual property in drug discovery.
The Drug Discovery Nexus Conference will feature a dynamic program, including expert-led sessions, panel discussions, and networking opportunities. Attendees will delve into the latest trends and technologies shaping the future of drug discovery, from AI and machine learning applications to sustainable chemistry practices.
Don't miss the opportunity to connect with industry leaders and explore the innovations driving the pharmaceutical sector forward. Register now to secure your place at the Drug Discovery Nexus Conference 2025 and be part of the conversation that is shaping the future of drug discovery.
Speaker
Ewa Gajewska,
Head of Product Management, SYNTHIA Retrosynthesis Software
Dr. Ewa Gajewska is the Head of Product Management at Merck KGaA, Darmstadt, Germany, where she leads the development of SYNTHIA Retrosynthesis Software – a groundbreaking software for computer-assisted synthetic planning. She graduated in biotechnology and chemistry from the Gdansk University of Technology and was a recipient of the Outstanding Achievements Award from Poland’s Minister of Science and Higher Education. In 2020 she received her PhD from the Institute of Organic Chemistry at the Polish Academy of Sciences. Her passion for tackling complex scientific challenges within commercial settings and the unique blend of her interdisciplinary skills drive the realization of innovative features of SYNTHIA Retrosynthesis Software.
